Results 111 to 120 of about 2,247 (204)

Tedizolid for Treatment of Enterococcal Bacteremia [PDF]

Open Forum Infectious Diseases, 2016
Praveen Sudhindra, Leslie Lee, Guiqing Wang, Abhay Dhand   +3 more
openaire   +1 more source

Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review

Tedizolid is a novel antibiotic of the class of oxazolidinones. This review evaluates the published literature on the optic and peripheral neuropathy associated with short and prolonged administration of tedizolid.
Katsarou, Angeliki, Palioura, Sotiria, Tzikopoulou, Maria, Falagas, Matthew E, Papadopoulos, Dimitrios   +4 more
core   +1 more source

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

Tedizolid phosphate (TR-701), a prodrug of tedizolid (TR-700), is a next-generation oxazolidinone that has shown favorable results in the treatment of acute bacterial skin and skin-structure infections in its first Phase III clinical trial. Tedizolid has
Grau, Santiago, Urbina, Olatz, Universitat Autònoma de Barcelona, Ferrández, Olivia, Espona, Mercè, Ferrández, Irene, Salas, Esther   +6 more
core  

A rare invader on a cardiac stent: <i>Mycobacterium abscessus</i> mediastinitis managed with tedizolid after linezolid intolerance. [PDF]

IDCases
Ajapuje PS, Gupta S, Chitre G, Samel S.
europepmc   +1 more source

Green stability-indicating RP-HPLC method for simultaneous bioanalysis of tedizolid phosphate and ciprofloxacin in human plasma. [PDF]

Sci Rep
El-Fatah GA, Mahmoud AM, Ahmed-Anwar AA, Farghali AA, Mahmoud R, Hassouna MEM.   +5 more
europepmc   +1 more source

Tedizolid Targets AQP9-JAK/STAT Axis to Suppress Metastatic Progression in Clear Cell Renal Cell Carcinoma: Mechanism and Therapeutic Implications. [PDF]

Int J Mol Sci
Qu K, Zhang T, Wang R, Bi Y, Jin J, Liu Y, Yi B, Zhu L, Wang J.   +8 more
europepmc   +1 more source

Advances in Therapeutic Drug Monitoring and Pharmacokinetic Researches of Oxazolidinone Antibacterial Agents in the Elderly Patients. [PDF]

Clin Interv Aging
Liu T, Li Z, Wei G, Yang Y, Wang F, Wang Y, Kang K, Yang P, Li H, Liu B, Fang X.   +10 more
europepmc   +1 more source

Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections. [PDF]

Drug Des Devel Ther
Zhao Y, Huang B, Yang Z, Kuang H, Chen J.   +4 more
europepmc   +1 more source

Rifamycin-, macrolide-, and ethambutol-free combinations to treat <i>Mycobacterium avium</i> complex lung disease. [PDF]

Int J Tuberc Lung Dis
Boorgula GD, Shrivastava A, Singh S, Galvez RA, McShane PJ, Devine M, Gumbo T, Srivastava S.   +7 more
europepmc   +1 more source

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. [PDF]

Pediatr Pulmonol
Fava J, Stephan E, Tansmore J, Sheikh S, Eisner M, Novak KJ.   +5 more
europepmc   +1 more source